Showing 4,641 - 4,660 results of 32,204 for search '(( 50 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( a step decrease ))', query time: 0.93s Refine Results
  1. 4641

    Synthesis and Activity of a Novel Autotaxin Inhibitor–Icodextrin Conjugate by Natalie Fisher (1860283)

    Published 2018
    “…The conjugate inhibits autotaxin activity (IC<sub>50</sub> = 0.86 ± 0.13 μg mL<sup>–1</sup>) and reduces cell migration. …”
  2. 4642
  3. 4643
  4. 4644
  5. 4645
  6. 4646

    Loss of <i>jag1b</i> function decreases the penetrance of <i>mef2ca</i>-associated phenotypes. by Juliana Sucharov (8067371)

    Published 2019
    “…Removing functional copies of <i>jag1b</i> decreased <i>mef2ca</i> mutant penetrance. Scale bar: 50 μm. …”
  7. 4647
  8. 4648
  9. 4649
  10. 4650
  11. 4651

    Decreased cardiomyocyte proliferation in <i>Nkx2.5-Cre/Foxm1<sup>fl/fl</sup></i> hearts. by Craig Bolte (299486)

    Published 2013
    “…“N” values were represented by boxes inside bars. Scale bars represent 50 µm in A–H and J–K and 10 µm in insets E–H.</p>…”
  12. 4652
  13. 4653
  14. 4654

    Decreased number of NeuN-positive neurons in the hippocampi of <i>Rere</i><sup>om/eyes3</sup> embryos. by Bum Jun Kim (381759)

    Published 2013
    “…<p>A) RERE immunohistochemistry analyses of mid-sagittal sections of the brain at E18.5. …”
  15. 4655

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Progression-free survival (PFS) and overall survival (OS) were evaluated by a Kaplan-Meier analysis and log-rank test. A Cox regression model was performed to identify independent prognostic factors.…”
  16. 4656

    Data_Sheet_1_Genetically Determined Lifestyle and Cardiometabolic Risk Factors Mediate the Association of Genetically Predicted Age at Menarche With Genetic Predisposition to Myoca... by Jilin Zheng (4029908)

    Published 2022
    “…Inverse variance weighted (IVW) MR analysis also showed that decrease in genetically predicted AAM was associated with higher genetically predicted alcohol intake frequency, current smoking behavior, higher waist-to-hip ratio, and higher levels of systolic blood pressure (SBP), fasting blood glucose, hemoglobin A1c (HbA1c), and triglycerides (TGs). …”
  17. 4657

    Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG by Meijuan Liu (4924417)

    Published 2019
    “…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”
  18. 4658

    Image_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG by Meijuan Liu (4924417)

    Published 2019
    “…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”
  19. 4659

    Table_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.DOCX by Meijuan Liu (4924417)

    Published 2019
    “…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”
  20. 4660

    Amastigote susceptibility (IC<sub>50</sub>) of the <i>in vitro</i> resistance selection procedure to PMM-MIL combination therapy. by Sarah Hendrickx (321143)

    Published 2017
    “…Exposure to 5 treatment cycles with either PMM (LEM3323 PMM) or MIL alone (LEM3323 MIL) revealed a clear decrease in drug susceptibility (indicated in bold) [<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005620#pntd.0005620.ref021" target="_blank">21</a>].…”